FOXBOROUGH, Mass.--(BUSINESS WIRE)--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN; Cyberkinetics) is scheduled to report its latest findings with respect to the Company’s BrainGate Neural Interface System (BrainGate System) in presentations at the Annual Meeting of the Society for Neuroscience in Atlanta, Georgia. The presentations will include scientific, mathematical data and practical observations related to a participant with quadriplegia and unable to speak as a result of a brainstem stroke, as well as the first participant with advanced ALS (amyotrophic lateral sclerosis, or Lou Gehrig’s disease). Cyberkinetics will make the details of its findings available following the completion of the presentations at the Society for Neuroscience.
